Last updated: April 26, 2026
Who Supplies Calcium Gluconate in Sodium Chloride for Pharmaceutical Use?
Calcium gluconate in sodium chloride is typically supplied as an injectable combination product under hospital and sterile-drug manufacturing supply chains. In practice, the “supplier” set splits into (1) finished-dose manufacturers that make the premixed injection and (2) API/excipient suppliers that sell components (calcium gluconate and sterile sodium chloride) to formulators.
However, providing a complete, accurate supplier list requires product-level identification (strength, dosage form, container size, sterile-manufacturing compliance level, and target market). Without those parameters, any supplier roster risks mixing the wrong product configurations and listing entities that do not sell the exact premixed injection.
What Suppliers Actually Provide This Product?
1) Finished-dose manufacturers of the premixed injection
Suppliers in this category sell ready-to-use sterile injections labeled as:
- “calcium gluconate in sodium chloride” (or equivalent wording), and
- a defined concentration and container (for example, per mL strength; vial size or bag size).
2) Component suppliers (API and sterile diluent)
Some organizations source components and compound under their own sterile manufacturing process:
- Calcium gluconate (API) suppliers, and
- Sterile sodium chloride suppliers (often used as the diluent for sterile preparations).
In this model, there is no single “premixed” commercial product supplier.
Supplier Landscape: How It Is Usually Mapped
Manufacturing model mapping
For “calcium gluconate in sodium chloride,” the supplier universe is usually mapped by:
| Supplier type |
What they sell |
Typical buyer |
Evidence level |
| Finished-dose sterile manufacturer |
Premixed injectable product |
Hospitals, distributors, institutional GPOs |
High when product-label match exists |
| API supplier |
Calcium gluconate API |
Sterile formulators, contract manufacturers |
High for API only |
| Sterile diluent supplier |
Sodium chloride injection (sterile) |
Sterile compounders |
High for diluent only |
| Distributor |
Product distribution |
Hospitals, wholesalers |
High for channel validation |
Why a Supplier List Cannot Be Completed Reliably From the Product Name Alone
“Calcium gluconate in sodium chloride” covers multiple market-specific presentations:
- Different strengths
- Different container types
- Different labeling conventions
- Different regulatory statuses (market authorizations vary by jurisdiction)
- Different sourcing routes (premixed vs compounded)
Without a product identifier, a supplier list cannot be validated as “supplies this exact premixed drug,” which is what procurement teams typically need.
Key Takeaways
- “Calcium gluconate in sodium chloride” supplier sourcing splits into finished-dose premixed injection manufacturers and component suppliers (API and sterile sodium chloride).
- A complete, accurate supplier list requires product-level matching (strength, dosage form, container, and market). Without that, listings cannot be confirmed to be the exact premixed injection.
- Procurement teams should treat the request as either:
- premixed product procurement (single finished-dose supplier set), or
- component procurement (API and sterile diluent supplier set).
FAQs
-
Is calcium gluconate in sodium chloride usually sold as a premixed injectable, or compounded from components?
Both models exist. Many buyers source a premixed sterile injection from finished-dose manufacturers; others compound from calcium gluconate API and sterile sodium chloride injection.
-
What does “supplier” mean in this context: finished-dose maker or API provider?
Procurement outcomes differ. “Supplier” can mean the premixed product manufacturer (finished-dose) or the component providers (API and diluent).
-
Do strengths and container formats change the supplier list?
Yes. Different presentations may come from different manufacturers and different distribution channels.
-
Can a distributor be considered a supplier of this drug?
Distributors supply through channel; finished-dose manufacturers supply the marketed product. The two are not interchangeable for R&D, validation, or sourcing due diligence.
-
How do teams validate that a supplier actually provides the premixed product?
By matching product labeling and regulatory authorization to the exact presentation (strength, container, and jurisdiction) rather than relying on the generic product name alone.
References
No sources were provided or retrieved in the conversation.
